1538. Who Will Benefit From Therapeutic Drug Monitoring of Ganciclovir?

BACKGROUND: Oral valganciclovir and intravenous ganciclovir are used for prophylaxis, treatment, and pre-emptive treatment of cytomegalovirus and human herpesvirus 6. It is important to estimate the exposure to these antivirals, as deviating levels can cause adverse events or induce acquired drug re...

Descripción completa

Detalles Bibliográficos
Autores principales: Martson, Anne-Grete, Sturkenboom, Marieke G G, Berger, Stefan P, Damman, Kevin, Verschuuren, Erik A M, Blokzijl, Hans, Bakker, Martijn, Span, Lambert F R, Touw, Daan J, van der Werf, Tjip S, Knoester, Marjolein, Alffenaar, Jan-Willem C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809420/
http://dx.doi.org/10.1093/ofid/ofz360.1402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809420/
http://dx.doi.org/10.1093/ofid/ofz360.1402

Ejemplares similares